Interferons Improve SARS-CoV-2 Viral Clearance

Research published in the journal Frontiers in Immunology revealed that interferons (IFN)may significantly improve virus clearance and reduce levels of inflammatory proteins in COVID-19 patients. The study included a cohort of 77 individuals with confirmed COVID-19. The cases were classified as moderate cases. The patients were treated with IFN-α2b plus ARB, and viral clearance was determined for each group. The study revealed a significantly different rate of viral clearance for each treatment. IFN-α2b treatment accelerated viral clearance by approximately 7 days.

Treatment with IFN-α2b, whether alone or in combination with ARB, accelerated viral clearance when compared to ARB treatment alone. The  IFN-α2b treatment significantly reduced the duration of detectable virus in the upper respiratory tract. The IFN treatment also significantly reduced circulating levels of CRP and IL-6. The influence of age, co-morbidities, and sex did not negate the effects of IFN treatment on viral clearance time. 

To know more about origin, virology of COVID-19, Click here

To know more about emerging themes in COVID-19, Click here

To know more about how WhiteCoats can help you in your professional advancement, visit www.whitecoats.com

Want to set up an online consultation for your practice, Click here

Ref Link: https://www.frontiersin.org/article/10.3389/fimmu.2020.01061

#Featured